Kristin M. Leiferman, MD

Professor of Dermatology, Medical Director for Regulatory Compliance and the Immunodermatology Laboratory, University of Utah School of Medicine

Specialties

• Dermatology
• Immunodermatology

Education

• Medical Degree—Mayo Medical School
• Residency—Dermatology, Mayo Clinic
• Research—Immunodermatology, Mayo Clinic

Certifications/Affiliations

• American Board of Dermatology (Dermatology and Dermatological Immunology/Diagnostic and Laboratory Immunology)

Research Interests

• Immune-mediated (humoral) cutaneous diseases, including immunobullous diseases
• Eosinophil-related inflammation in epithelial tissues
• Allergic inflammation in epithelial tissues, including IgE, mast cell, and basophil-related

Awards

• Best Doctors in America 2001
• Who’s Who in America 2003
• National Institutes of Health Grant Awards

Recent Publications

• Lehman JS, Fernandez AP, Leiferman KM, et al. Assessment of cutaneous and mucosal direct immunofluorescence testing practices in the US. JAMA Dermatol. 2025;161(7):747-754.
• Leiferman KM, Gleich GJ. The true extent of eosinophil involvement in disease is unrecognized: the secret life of dead eosinophils. J Leukoc Biol. 2024;116(2):271-287.
• Valent P, Klion AD, Roufosse F, et al. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes. Allergy. 2023;78(1):47-59.
• Leiferman KM, Snook JP, Khalighi MA, et al. Diagnostics for dermatologic diseases with autoantibodies. J Appl Lab Med. 2022;7(1):165-196.
• Leiferman KM, Peters MS. Eosinophil-related disease and the skin. J Allergy Clin Immunol Pract. 2018;6(5):1462-1482.e6.